![]() |
Atopix Therapeutics, Chief Medical Officer
Clinical Development Consultant to Annapurna Therapeutics, Adverum Biotechnologies, Circassia, Theracos, Ferrumax, Kyowa Hakko Kirin, GSK, and Novartis
Vice-President and Medicine Development Leader (diabetes, immunoinflammation), GSK
Cardiovascular Clinical Head (Europe), GSK
Research Fellow in Clinical Pharmacology, Imperial College, London, UK
Research Fellow in Cardiology, Green Lane Hospital, Auckland, New Zealand
Licensed UK physician (St. George’s Hospital Medical School)
Dual board certified UK specialist in Clinical Pharmacology and Pharmaceutical Medicine
Member of the Royal College of Physicians of London
Fellow of the Faculty of Pharmaceutical Medicine, London
![]() |
Marie-Curie PhD (to be submitted), University of Exeter Medical School, UK
Clinical Research Training Course (2018), Missione CRA – YGHEA, Milan, Italy
Fellowship & Internship during the Master’s degree (2011-2013), San Raffaele Scientific Institute, Milan, Italy
Master’s degree in Drug Biotechnology (2012), University of Milan, Italy
![]() |
>15 as Project Manager of the Prostate Cancer Program at Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Coordination of observational protocols of active surveillance in prostate cancer and of projects on interdisciplinary and multiprofessionale management of oncologic patients
Concept and management of collaborative strategies with national and international partners with respect to preclinical, translational and clinical research
Auditor for the Organization of European Cancer Centres (OECI)
Member of the Board of Experts for the Agenzia Nazionale per i servizi sanitari Regionali (AGENAS) – Minister of Health “Clinical/Organizational/Epidemiologic/Social Group” e “Research and International Relationships”
Author of > 20 papers, h-index 9, >380 citations
Editor and author of the book “Tumore della prostata. Paziente, familiari e medici: esperienze narrate” published by Springer Verlag in 2013